Clinical Trials Directory

Trials / Completed

CompletedNCT05984329

Tonic Versus Burst DR(TM) Epidural Motor Cortex Stimulation for Neuropathic Pain

Tonic Versus Burst DR(TM) Epidural Motor Cortex Stimulation for Neuropathic Pain : a Double-blind, Crossover, Comparative Study

Status
Completed
Phase
Study type
Observational
Enrollment
14 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Epidural stimulation of the primary motor cortex (PMC) is indicated for the relief of neuropathic pain refractory to pharmacological treatment.

Detailed description

The main objective of this study is to compare the analgesic effect of two distinct waveforms (i.e. tonic versus Burst DR(TM)) delivered by an epidural stimulator of the (primary) motor cortex in patients suffering from neuropathic pain resistant to the best pharmacological treatment.

Conditions

Interventions

TypeNameDescription
OTHERRetrospective analysis of patients' choiceRetrospective analysis of patients' choice of tonic or Burst DR(TM) waves for their analgesic effect.

Timeline

Start date
2022-07-15
Primary completion
2024-05-15
Completion
2024-05-15
First posted
2023-08-09
Last updated
2024-08-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05984329. Inclusion in this directory is not an endorsement.

Tonic Versus Burst DR(TM) Epidural Motor Cortex Stimulation for Neuropathic Pain (NCT05984329) · Clinical Trials Directory